Rebel Medicine

Rebel Medicine is developing the next generation of local anesthetics to eliminate opioids after surgery. The company's solution is an injectable, extended-release bupivacaine gel that provides four days of non-opioid postoperative pain relief after a single administration in any surgical scenario. It utilizes a simple, clever design with extremely low COGS, enabling the company to sell its drugs at a price the customer is actually willing to pay.